HemoSense, Inc.

Cardinal Health to market, sell, and distribute INRatio product line in U.S.

Published in Surgery Litigation and Law Weekly, October 29th, 2004

HemoSense, Inc., announced the signing of an exclusive 3-year agreement with Cardinal Health, Inc., (CAH) to market, sell, and distribute HemoSense's INRatio product line to health-care providers in the United States.

Under the agreement, Cardinal Health will provide the INRatio product line to physician offices, clinics, surgery centers, and ambulatory centers within integrated delivery networks (IDNs). Financial terms were not disclosed.

The portable INRatio monitors prothrombin time (PT) for appropriate anticoagulation therapy in patients who are taking Coumadin, a blood thinning drug.

Anticoagulation patients typically have...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly

Source: Surgery Litigation and Law Weekly (2004-10-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry